IRD
Opus Genetics Inc.

463
Mkt Cap
$312.34M
Volume
847,023.00
52W High
$5.30
52W Low
$0.65
PE Ratio
-5.21
IRD Fundamentals
Price
$4.39
Prev Close
$4.58
Open
$4.56
50D MA
$3.42
Beta
0.98
Avg. Volume
1.15M
EPS (Annual)
-$0.797
P/B
19.99
Rev/Employee
$507,000.00
$81.10
Loading...
Loading...
News
all
press releases
Opus Genetics (NASDAQ:IRD) Insider Rabourn Amy Zaremba Sells 2,816 Shares
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) insider Rabourn Amy Zaremba sold 2,816 shares of the business's stock in a transaction on Monday, March 16th. The shares were sold at an average...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Insider Selling: Opus Genetics (NASDAQ:IRD) Insider Sells 2,816 Shares of Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) insider Rabourn Amy Zaremba sold 2,816 shares of the company's stock in a transaction that occurred on Monday, March 16th. The shares were sold at...
MarketBeat·4d ago
News Placeholder
Insider Selling: Opus Genetics (NASDAQ:IRD) Insider Sells $19,041.28 in Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) insider Ashwath Jayagopal sold 3,719 shares of Opus Genetics stock in a transaction on Monday, March 16th. The shares were sold at an average price...
MarketBeat·4d ago
News Placeholder
Joseph Schachle Sells 3,719 Shares of Opus Genetics (NASDAQ:IRD) Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) COO Joseph Schachle sold 3,719 shares of the business's stock in a transaction dated Monday, March 16th. The shares were sold at an average price of...
MarketBeat·4d ago
News Placeholder
Insider Selling: Opus Genetics (NASDAQ:IRD) CEO Sells 24,438 Shares of Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) CEO George Magrath sold 24,438 shares of the stock in a transaction on Monday, March 16th. The stock was sold at an average price of $5.21, for a...
MarketBeat·4d ago
News Placeholder
Opus Genetics, Inc. (NASDAQ:IRD) Short Interest Up 17.9% in February
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) was the target of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 1,110,696...
MarketBeat·6d ago
News Placeholder
Oppenheimer Initiates Coverage on Opus Genetics (NASDAQ:IRD)
Oppenheimer began coverage on shares of Opus Genetics in a report on Monday. They set an "outperform" rating and a $10.00 price target for the company...
MarketBeat·6d ago
News Placeholder
HC Wainwright Has Negative View of Opus Genetics Q1 Earnings
Opus Genetics, Inc. (NASDAQ:IRD - Free Report) - Equities research analysts at HC Wainwright lowered their Q1 2026 earnings per share estimates for Opus Genetics in a research note issued to...
MarketBeat·9d ago
News Placeholder
Lifesci Capital Forecasts Lower Earnings for Opus Genetics
Opus Genetics, Inc. (NASDAQ:IRD - Free Report) - Research analysts at Lifesci Capital decreased their Q1 2026 EPS estimates for shares of Opus Genetics in a research report issued on Tuesday, March...
MarketBeat·9d ago
News Placeholder
Opus Genetics (NASDAQ:IRD) Given New $10.00 Price Target at Wedbush
Wedbush raised their target price on shares of Opus Genetics from $8.00 to $10.00 and gave the company an "outperform" rating in a report on Thursday...
MarketBeat·10d ago
<
1
2
...
>

Latest IRD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.